Which Key Players hold a major share of global Breast Cancer Diagnostics Market?

 Breast Cancer Diagnostics Industry Overview

The global Breast Cancer Diagnostics Market size is expected to reach USD 6.8 billion by 2028, according to a new study by Grand View Research Inc. The market is expected to expand at a CAGR of 7.0% from 2021 to 2028. The growth is largely attributable to the increasing geriatric population exposed to the risk of breast cancer and early detection coupled with increasing awareness about breast cancer.

The introduction of 3D mammography or digital breast tomosynthesis, which is more accurate than 2D mammography, supports market growth. This advanced technology can detect 40.0% more cancers than 2D mammograms and reduce patient recalls. Rapid technological advancements are a major factor expected to drive the market over the coming years.

Breast Cancer Diagnostics Market Segmentation

Grand View Research has segmented the global breast cancer diagnostics market on the basis of type, product, application, end-use, and region:

Based on the Type Insights, the market is segmented into Imaging, Biopsy, Genomic Tests, Blood Tests, and Others

  • The imaging segment dominated the market for breast cancer diagnostics and accounted for the largest revenue share of 73.6% in 2020.
  • The blood tests segment is projected to be the fastest-growing segment during the forecast period due to several research studies being carried out globally by the research organizations and major players.

Based on the Product Insights, the market is segmented into Platform-based Products and Instrument-based Products

  • The instrument-based testing segment dominated the market for breast cancer diagnostics and accounted for the largest revenue share of 72.7% in 2020.
  • The platform-based products segment is anticipated to witness the fastest growth over the forecast period, owing to the novelty of products and the higher preference of such products for the targeted therapy.

Based on the Application Insights, the market is segmented into Screening, Diagnostic and Predictive, Prognostic, and Research

  • The diagnostics and predictive application segment dominated the market for breast cancer diagnostics and accounted for the largest revenue share of around 47.6% in 2020.
  • The prognostic segment is expected to witness a significant CAGR over the forecast period.

Based on the End-use Insights, the market is segmented into Hospitals & Clinics, Diagnostic Centers and Medical Laboratories, and Others

  • The hospitals and clinics segment dominated the market for breast cancer diagnostics and accounted for the largest revenue share of around 50.2% in 2020.
  • The diagnostic centers and medical laboratories segment is expected to witness a significant growth rate over the forecast period due to an increase in the number of initiatives undertaken by governments to provide various services, such as reimbursement for diagnostic tests.

Breast Cancer Diagnostics Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The key companies are adopting strategies such as mergers and acquisitions and partnerships, to acquire a larger market share, globally.

Some prominent players in the global Breast Cancer Diagnostics market include:

  • Hologic Inc.
  • Genomic Health (Exact Sciences Corporation)
  • BD
  • Danaher
  • Koninklijke Philips N.V.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Myriad Genetics
  • Argon Medical Devices, Inc.
  • Hoffmann-La Roche Ltd.

Order a free sample PDF of the Breast Cancer Diagnostics Market Intelligence Study, published by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

Spinal Implants & Devices Market Forecast Analysis by Manufacturer, Types, Applications and Regions 2023 – 2030

  Spinal Implants & Devices Industry Overview The global  Spinal Implants & Devices Market  size is expected to reach USD 19.0 billion by 2030 and is expected to expand at a CAGR of 5.2% in the forecast period, from 2023 to 2030, according to a new report by Grand View Research, Inc. The growing number of vehicular accidents is leading to increasing new cases of spinal cord injuries (SCIs). Other causes of SCIs include falls, violence, acts of violence, sports and recreation injuries, and diseases. Vehicular or road accidents and falls account for the majority of SCI cases. Fall-induced SCI is common among people aged 65 years and above. Acts of violence such as gunshot wounds or knife wounds account for around 12% of SCI cases. Sports activities such as diving in shallow water and impact sports lead to nearly 10% of SCIs. Cancer, osteoporosis, arthritis, and inflammation of the spinal cord also cause SCI. Based on National Spinal Cord Injury Statistical Center da...
Read more

Latin America Pharmaceutical Contract Manufacturing & Research Services Market Overview, Cost Structure Analysis and Forecast to 2030

  Latin America Pharmaceutical Contract Manufacturing & Research Services Industry Overview The  Latin America Pharmaceutical Contract Manufacturing & Research Services Market  size is expected to reach USD 40.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 7.5% from 2022 to 2030. The low cost of drug registration in Latin American countries and the economic growth are the key factors contributing to progress in this region. Moreover, factors such as the growing demand for generics, rising investments in R&D, the growing geriatric population, and the increasing burden of chronic diseases are responsible for market growth. The outbreak of COVID-19 has boosted the market growth as companies have increased investments in R&D and manufacturing to develop vaccines and drugs against the COVID-19. During the coronavirus outburst, the supply chains of biopharmaceutical companies remained robust...
Read more

Europe Orthopedic Navigation Systems Market - Global Industry Insights, Trends and Growth Opportunity Analysis to 2030

  Europe Orthopedic Navigation Systems Industry Overview The  Europe Orthopedic Navigation Systems Market  size is expected to reach USD 2,504.4 million by 2030, according to a new report published by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.8% from 2023 to 2030. The rising number of target diseases especially in the geriatric population is responsible for the rapid growth of the market. According to the Executive Agency for Health and Consumers, one in ten people in the geriatric population in Europe is suffering from osteoarthritis. Minimal invasion and low post-operative complications associated with computer-assisted surgery are anticipated to drive regional market growth over the forecast period. Moreover, the introduction of technologically advanced products is expected to induce demand for  orthopedic navigation systems . For instance, Orthokey Italia developed a new version of KiRA system integrating it with the iPad to ...
Read more